GC
SGNT

Globeflex Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Globeflex Capital’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-33,800
Closed -$857K – 740
2013
Q4 		$857K Buy
33,800
+7,300
+28% +$165K 0.1% 234
2013
Q3 		$540K Buy
+26,500
New +$590K 0.07% 284

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Globeflex Capital's SGNT Position: Q1 2014 in Review

Globeflex Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2014, closing a stake of 33,800 shares — an estimated $857K sold.

Globeflex Capital first reported a position in SGNT in Q3 2013 and held it in 2 quarters. The position peaked at $857K in Q4 2013. 94 funds tracked by Wall St. Rank hold SGNT as of Q1 2014.

  • Globeflex Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • Globeflex Capital sold 33,800 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2014, an estimated $857K.
  • Globeflex Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 2 quarters.
  • Globeflex Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $857K in Q4 2013.
  • 94 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2014.

Based on Globeflex Capital's 13F filing for Q1 2014, filed 23 Apr 2014.